open9 vistas
India
IndiaBiopharma SHAKTI Mission 2026
A ₹10,000 crore flagship mission announced in Union Budget 2026-27 to position India as a global biotech and biopharma leader. The mission provides grants, equity support, and subsidised loans to biotech startups, MSMEs, and large pharma companies investing in vaccine development, biologics manufacturing, biosimilar production, and genomics research.
Quién puede solicitar
Biotech and biopharma companies registered in India, startups registered with DPIIT, MSMEs in pharma/biotech sector, research institutions and academic spin-offs with technology readiness, large pharma companies for manufacturing scale-up in biosimilars, vaccines, cell & gene therapy.Beneficios y ventajas
- Grants
- Equity support
- Subsidised loans
Contactos clave
Sanket Ghogare
Editor
Fuentes
Enlaces utilizados por la IA para recopilar información sobre esta subvención.
- schemesinindia.in/central/biopharma-shakti-mission-india ↗
- birac.nic.in/ ↗
- pib.gov.in/PressNoteDetails.aspx?NoteId=157147&ModuleId=3®=3&lang=1 ↗
- economictimes.indiatimes.com/news/economy/policy/budget-2026-union-budget-2026-b… ↗
- static.pib.gov.in/WriteReadData/specificdocs/documents/2026/feb/doc202622776701.… ↗
- www.insightsonindia.com/2026/02/02/biopharma-shakti-initiative/ ↗